Learn more

CARRINGTON LAB INC

Overview
  • Total Patents
    119
About

CARRINGTON LAB INC has a total of 119 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are PHARMACOSMOS HOLDING AS, GALENICA PHARMACEUTICALS INC and IVAX RESEARCH INC.

Patent filings per year

Chart showing CARRINGTON LAB INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mcanalley Bill H 58
#2 Yates Kenneth M 44
#3 Ni Yawei 29
#4 Carpenter Robert H 24
#5 Mcdaniel Harley R 18
#6 Moore D Eric 14
#7 Hall John E 10
#8 Zarzycki Ryszard 6
#9 Boyd Stephen 6
#10 Rodriguez Santiago 6

Latest patents

Publication Filing date Title
WO2008073490A1 Purification of influenza viral antigens
US7494669B2 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US2003175370A1 Dispersed solid-containing complex carbohydrate
US2003147876A1 Combination of a growth factor and a protease enzyme
US6777000B2 In-situ gel formation of pectin
US7022683B1 Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6313103B1 Pectic substance as a growth factor stabilizer
US5929051A Aloe pectins
US5925357A Bifurcated method to process aloe whole leaf
CA2245527A1 Uses of denture adhesive containing aloe extract
US5760102A Uses of denture adhesive containing aloe extract
US5902796A Bioactive factors of aloe vera plants
US5512488A Colorimetric assay for bioactive polysaccharide
US5468737A Wound healing accelerated by systemic administration of polysaccharide from aloe
US5443830A Drink containing mucilaginous polysaccharides and its preparation
US5409703A Dried hydrogel from hydrophilic-hygroscopic polymer
CA2112123A1 Wound cleanser
US5308838A Uses of aloe products
EP0965346A2 Use of acetylated mannan derivatives for treating chronic respiratory diseases
KR100209180B1 Pharmaceutical composition containing acemannan